🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Prospective Comparative Multicenter Study of the Care Pathway After Shoulder Surgery

RecruitingNAAges 18 Years - anyAllClinique Victor Hugo
NCT06808269 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Post-operative management of shoulder surgery patients, particularly in terms of pain management and follow-up, can vary from one center to another, influencing clinical outcomes and patient satisfaction. The aim of this study is to compare two approaches to post-operative follow-up in two distinct centers: structured follow-up using the Vivalto-Dom protocol in Paris, and autonomous follow-up through contact with a nurse in Saint-Grégoire. The hypothesis is that these differences in the care pathway will affect pain management, comfort and patient satisfaction. By controlling for operative variability (a single surgeon operating in both centers), the study will identify the most effective follow-up practices for improving post-operative management, with the ultimate aim of optimizing quality of care and reducing post-operative complications.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patient eligible for one of the following 4 types of surgery: Simple non-repair arthroscopic surgery (acromion, calcification), arthroscopic repair surgery (cuff, DAS, bankart), open surgery without prosthesis (ligamentoplasty, bone block), open surgery with prosthesis (inverted prosthesis, anatomic prosthesis, etc.). Exclusion Criteria: * Patients with one or more communication disorders. * Pregnant or breast-feeding patients * Patients not covered by a social security scheme * Refusal to participate in research * Patients unable to understand or give informed consent * Patients under guardianship, deprived of liberty or under court protection * Patients with past or present drug addiction * Patients with neuropathy * Patients with cognitive disorders * Patients with chronic illnesses or inflammatory pathologies leading to chronic pain.
💊

What it tests

  • Vivalto Dom follow-up
  • Liberal follow-up
📍

Where

2 sites
Clinique Victor Hugo
Paris, France
Centre hospitalier privé Saint-Grégoire
Saint-Grégoire, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy